Centessa Pharmaceuticals plc(CNTA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CNTA Centessa Pharmaceuticals plc

交易中 01-13 15:35:48 EST

22.33

+0.31

+1.41%

最高22.47	最低21.80	成交量32.97万
今开22.00	昨收22.02	日振幅3.04%
总市值32.60亿	流通市值21.69亿	总股本1.46亿
成交额728.29万	换手率0.34%	流通股本9,713万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CNTA","market":"US","secType":"STK","nameCN":"Centessa Pharmaceuticals plc","latestPrice":22.33,"timestamp":1768336546067,"preClose":22.02,"halted":0,"volume":329739,"delay":0,"floatShares":97125800,"shares":146000000,"eps":-1.821169,"marketStatus":"交易中","change":0.31,"latestTime":"01-13 15:35:48 EST","open":22,"high":22.47,"low":21.8,"amount":7282914.297534,"amplitude":0.030427,"askPrice":22.34,"askSize":24,"bidPrice":22.31,"bidSize":106,"shortable":3,"etf":0,"ttmEps":-1.821169,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768338000000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1622174400000,"exchange":"NASDAQ","adjPreClose":22.02,"preHourTrading":{"tag":"盘前","latestPrice":22.2,"preClose":22.02,"latestTime":"08:37 EST","volume":25,"amount":555,"timestamp":1768311431946},"postHourTrading":{"tag":"盘后","latestPrice":22.02,"preClose":22.02,"latestTime":"16:10 EST","volume":3516,"amount":77422.32,"timestamp":1768252204093},"volumeRatio":0.285126,"impliedVol":0.9552,"impliedVolPercentile":0.5418},"requestUrl":"/m/hq/s/CNTA","defaultTab":"news","newsList":[{"id":"1157010904","title":"Centessa Pharmaceuticals PLC 任命Mario Alberto Accardi为首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=1157010904","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157010904?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:57","pubTimestamp":1765457848,"startTime":"0","endTime":"0","summary":"12月11日 - Centessa Pharmaceuticals PLC（）宣布任命Mario Alberto Accardi为首席执行官，并将于2026年1月1日生效，Saurabh Saha将卸任首席执行官。此外，Centessa Pharmaceuticals PLC还透露，ORX750的注册项目预计将在2026年第一季度启动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTA","BK4139","BK4535","BK4539"],"gpt_icon":0},{"id":"2585717951","title":"Centessa Pharmaceuticals Plc盘中异动 下午盘急速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585717951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585717951?lang=zh_cn&edition=full","pubTime":"2025-11-22 03:08","pubTimestamp":1763752095,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日03时08分，Centessa Pharmaceuticals Plc股票出现波动，股价大幅拉升5.12%。截至发稿，该股报28.95美元/股，成交量81.4362万股，换手率0.55%，振幅4.90%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为1.33%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112203081697782ca9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112203081697782ca9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","CNTA","BK4535"],"gpt_icon":0},{"id":"1187094309","title":"Centessa Pharmaceuticals宣布250,000,000美元美国存托股份公开发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1187094309","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187094309?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:26","pubTimestamp":1763573216,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals PLC宣布了其250,000,000美元美国存托股份（ADS）公开发行的定价。此次发行定价为1160万股ADS，每股的公众发售价为21.50美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTA","BK4535","BK4539"],"gpt_icon":0},{"id":"2583630934","title":"Centessa Pharmaceuticals Plc盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583630934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583630934?lang=zh_cn&edition=full","pubTime":"2025-11-15 01:11","pubTimestamp":1763140300,"startTime":"0","endTime":"0","summary":"北京时间2025年11月15日01时11分，Centessa Pharmaceuticals Plc股票出现波动，股价急速拉升5.02%。截至发稿，该股报27.27美元/股，成交量156.402万股，换手率1.07%，振幅5.12%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为1.38%。其相关个股中，Cidara Therapeutics, Inc.、Cypherpunk Technologies Inc.、Traws Pharma, Inc.涨幅较大，Aspire Biopharma Holdings, Inc.、Cypherpunk Technologies Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为1008.05%、309.86%、160.83%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cypherpunk Technologies Inc.、Hcw Biologics Inc.，振幅分别为101.46%、94.31%、59.44%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115011141a4a21714&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115011141a4a21714&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4535","CNTA","BK4139"],"gpt_icon":0},{"id":"2583305358","title":"Centessa Pharmaceuticals Plc盘中异动 股价大涨5.18%报23.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583305358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583305358?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:37","pubTimestamp":1762958237,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日22时37分，Centessa Pharmaceuticals Plc股票出现波动，股价快速上涨5.18%。截至发稿，该股报23.71美元/股，成交量133.239万股，换手率0.99%，振幅7.23%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Leap Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Salarius Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为4997.26%、307.20%、82.67%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Salarius Pharmaceuticals, Inc.、Leap Therapeutics, Inc.，振幅分别为46.48%、43.88%、29.67%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112223717a6f4b6ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112223717a6f4b6ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CNTA","BK4535","BK4539"],"gpt_icon":0},{"id":"1121229717","title":"Centessa Pharmaceuticals plc：Wells Fargo启动覆盖并给予超配评级，目标价31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121229717","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121229717?lang=zh_cn&edition=full","pubTime":"2025-09-03 19:05","pubTimestamp":1756897510,"startTime":"0","endTime":"0","summary":"Centessa Pharmaceuticals plc：Wells Fargo启动覆盖并给予超配评级，目标价31美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTA","BK4139","BK4535","BK4539"],"gpt_icon":0},{"id":"2557537315","title":"Centessa Pharmaceuticals Plc盘中异动 下午盘股价大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557537315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557537315?lang=zh_cn&edition=full","pubTime":"2025-08-06 01:07","pubTimestamp":1754413629,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日01时07分，Centessa Pharmaceuticals Plc股票出现波动，股价大幅拉升5.35%。截至发稿，该股报16.94美元/股，成交量54.1348万股，换手率0.41%，振幅5.47%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体跌幅为3.31%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806010710a476ffb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806010710a476ffb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTA","BK4539","BK4535","BK4139"],"gpt_icon":0},{"id":"2555296880","title":"Centessa Pharmaceuticals Plc盘中异动 下午盘大幅拉升5.05%报15.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555296880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555296880?lang=zh_cn&edition=full","pubTime":"2025-07-31 02:41","pubTimestamp":1753900887,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日02时41分，Centessa Pharmaceuticals Plc股票出现波动，股价快速拉升5.05%。截至发稿，该股报15.98美元/股，成交量39.0937万股，换手率0.29%，振幅4.50%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为0.70%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731024127a46bffef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731024127a46bffef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTA","BK4139","BK4539","BK4535"],"gpt_icon":0},{"id":"2518797012","title":"Centessa Pharmaceuticals Plc盘中异动 早盘股价大跌5.05%报15.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518797012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518797012?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:57","pubTimestamp":1741615079,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时57分，Centessa Pharmaceuticals Plc股票出现波动，股价急速下跌5.05%。截至发稿，该股报15.41美元/股，成交量6.0309万股，换手率0.05%，振幅3.20%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2984.09%、651.03%、238.07%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215759abf30685&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215759abf30685&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4535","CNTA","BK4139"],"gpt_icon":0},{"id":"2514533204","title":"Centessa Pharmaceuticals Plc盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514533204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514533204?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:27","pubTimestamp":1740688031,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时27分，Centessa Pharmaceuticals Plc股票出现异动，股价急速下挫5.03%。截至发稿，该股报15.11美元/股，成交量58.241万股，换手率0.44%，振幅6.66%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1927.61%、377.70%、194.73%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280427129632f1b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280427129632f1b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTA","BK4539","BK4139","BK4535"],"gpt_icon":0},{"id":"2514019789","title":"Centessa Pharmaceuticals Plc盘中异动 急速下挫5.11%报14.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514019789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514019789?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:23","pubTimestamp":1740500609,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时23分，Centessa Pharmaceuticals Plc股票出现异动，股价大幅下挫5.11%。截至发稿，该股报14.86美元/股，成交量22.0889万股，换手率0.17%，振幅4.92%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1329.77%、1114.36%、901.29%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为224.93%、87.83%、66.67%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600232996300ad0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600232996300ad0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTA","BK4139","BK4539","BK4535"],"gpt_icon":0},{"id":"2514770232","title":"Centessa Pharmaceuticals Plc盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514770232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514770232?lang=zh_cn&edition=full","pubTime":"2025-02-25 03:44","pubTimestamp":1740426240,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日03时44分，Centessa Pharmaceuticals Plc股票出现波动，股价快速下挫5.17%。截至发稿，该股报15.77美元/股，成交量30.2842万股，换手率0.23%，振幅5.92%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为323.98%、137.91%、40.17%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、162.04%、81.92%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225034401abdb4ffb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225034401abdb4ffb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTA","BK4539","BK4139","BK4535"],"gpt_icon":0},{"id":"2512916641","title":"Centessa Pharmaceuticals Plc盘中异动 早盘快速下跌6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512916641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512916641?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889106,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Centessa Pharmaceuticals Plc股票出现异动，股价快速下跌6.09%。截至发稿，该股报16.03美元/股，成交量1.5654万股，换手率0.01%，振幅1.76%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为275.65%、90.83%、59.36%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Allakos Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为8.57%、6.84%、6.13%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223146abd3af16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223146abd3af16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","CNTA","BK4535"],"gpt_icon":0},{"id":"2511696128","title":"Centessa Pharmaceuticals Plc盘中异动 股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511696128?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:36","pubTimestamp":1739543793,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时36分，Centessa Pharmaceuticals Plc股票出现异动，股价大幅拉升5.28%。截至发稿，该股报18.55美元/股，成交量5.7828万股，换手率0.04%，振幅3.69%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1235.22%、380.55%、364.53%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为49.61%、21.52%、20.20%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223633abcf07b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223633abcf07b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VRPX","BK4539","CNTA","BK4535","BK4007"],"gpt_icon":0},{"id":"2510863405","title":"Centessa Pharmaceuticals Plc盘中异动 股价大跌6.20%报17.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510863405?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:32","pubTimestamp":1739197962,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时32分，Centessa Pharmaceuticals Plc股票出现波动，股价快速下跌6.20%。截至发稿，该股报17.85美元/股，成交量10.3113万股，换手率0.08%，振幅5.15%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为1710.24%、866.95%、581.35%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.，振幅分别为30.46%、26.71%、16.04%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102232439880783e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102232439880783e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CNTA","OCEA","BK4139","BK4539"],"gpt_icon":0},{"id":"2509776780","title":"Centessa Pharmaceuticals Plc盘中异动 急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509776780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509776780?lang=zh_cn&edition=full","pubTime":"2025-02-08 04:38","pubTimestamp":1738960697,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日04时38分，Centessa Pharmaceuticals Plc股票出现异动，股价急速上涨5.10%。截至发稿，该股报18.75美元/股，成交量78.6641万股，换手率0.60%，振幅5.65%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体跌幅为0.87%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208043817a23d6ed5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208043817a23d6ed5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTA","BK4535","BK4139","BK4539"],"gpt_icon":0},{"id":"2509259878","title":"Centessa Pharmaceuticals Plc盘中异动 临近收盘股价大涨5.06%报17.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509259878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509259878?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:57","pubTimestamp":1738789056,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时57分，Centessa Pharmaceuticals Plc股票出现异动，股价大幅上涨5.06%。截至发稿，该股报17.24美元/股，成交量20.5957万股，换手率0.16%，振幅5.91%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为1.97%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Invivyd, Inc.、Transcode Therapeutics, Inc.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4731.72%、2453.23%、1790.36%，振幅较大的相关个股有Oragenics Inc.、Invivyd, Inc.、Transcode Therapeutics, Inc.，振幅分别为132.24%、108.79%、99.51%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206045736abc3cc5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206045736abc3cc5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","BK4539","CNTA"],"gpt_icon":0},{"id":"2506049511","title":"Centessa Pharmaceuticals Plc盘中异动 早盘股价大跌5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506049511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506049511?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:34","pubTimestamp":1738074894,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时34分，Centessa Pharmaceuticals Plc股票出现异动，股价急速下挫5.54%。截至发稿，该股报15.51美元/股，成交量1208股，换手率0.00%，振幅0.00%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Hepion Pharmaceuticals, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为711.90%、222.91%、151.44%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Allarity Therapeutics, Inc.、Zymeworks Inc.，振幅分别为113.08%、103.25%、101.04%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282234549612f4b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282234549612f4b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTA","BK4535","BK4139","BK4539"],"gpt_icon":0},{"id":"2505272870","title":"Centessa Pharmaceuticals Plc盘中异动 早盘急速上涨5.07%报15.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505272870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505272870?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:31","pubTimestamp":1737469911,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时31分，Centessa Pharmaceuticals Plc股票出现异动，股价快速拉升5.07%。截至发稿，该股报15.93美元/股，成交量3114股，换手率0.00%，振幅4.87%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Dogwood Therapeutics, Inc.、Replimune Group, Inc.、Allakos Inc.涨幅较大，Dogwood Therapeutics, Inc.、Dermata Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为520.15%、161.04%、27.09%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Allakos Inc.、Equillium, Inc.，振幅分别为148.13%、111.05%、107.00%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223151a22a5702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223151a22a5702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CNTA","BK4539"],"gpt_icon":0},{"id":"2504919505","title":"Centessa Pharmaceuticals Plc盘中异动 早盘急速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504919505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504919505?lang=zh_cn&edition=full","pubTime":"2025-01-18 00:22","pubTimestamp":1737130967,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日00时22分，Centessa Pharmaceuticals Plc股票出现异动，股价大幅拉升5.01%。截至发稿，该股报15.62美元/股，成交量12.1178万股，换手率0.09%，振幅6.66%。Centessa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为0.57%。Centessa Pharmaceuticals Plc公司简介：Centessa Pharmaceuticals PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118002248986a2f55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118002248986a2f55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4535","CNTA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.centessa.com","stockEarnings":[{"period":"1week","weight":-0.0434},{"period":"1month","weight":-0.1694},{"period":"3month","weight":-0.0174},{"period":"6month","weight":0.407},{"period":"1year","weight":0.4079},{"period":"ytd","weight":-0.1196}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Centessa Pharmaceuticals plc于2020年10月26日在英国注册成立。该公司是一家临床阶段的制药公司，其使命是发现、开发并最终交付对患者具有变革性的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.011235},{"month":2,"riseRate":0.25,"avgChangeRate":0.004574},{"month":3,"riseRate":0.75,"avgChangeRate":0.02482},{"month":4,"riseRate":0.25,"avgChangeRate":-0.009467},{"month":5,"riseRate":0,"avgChangeRate":-0.150221},{"month":6,"riseRate":0.8,"avgChangeRate":0.098968},{"month":7,"riseRate":0.6,"avgChangeRate":0.113087},{"month":8,"riseRate":0.6,"avgChangeRate":0.057921},{"month":9,"riseRate":0.4,"avgChangeRate":0.033671},{"month":10,"riseRate":0.6,"avgChangeRate":0.00007},{"month":11,"riseRate":0.6,"avgChangeRate":-0.006712},{"month":12,"riseRate":0.2,"avgChangeRate":-0.030273}],"exchange":"NASDAQ","name":"Centessa Pharmaceuticals plc","nameEN":"Centessa Pharmaceuticals plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Centessa Pharmaceuticals plc(CNTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Centessa Pharmaceuticals plc(CNTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Centessa Pharmaceuticals plc,CNTA,Centessa Pharmaceuticals plc股票,Centessa Pharmaceuticals plc股票老虎,Centessa Pharmaceuticals plc股票老虎国际,Centessa Pharmaceuticals plc行情,Centessa Pharmaceuticals plc股票行情,Centessa Pharmaceuticals plc股价,Centessa Pharmaceuticals plc股市,Centessa Pharmaceuticals plc股票价格,Centessa Pharmaceuticals plc股票交易,Centessa Pharmaceuticals plc股票购买,Centessa Pharmaceuticals plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Centessa Pharmaceuticals plc(CNTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Centessa Pharmaceuticals plc(CNTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}